Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Rimonabant on Liver Fat and Visceral Adipose Tissue in Obese Subjects with Metabolic Syndrome
2007-000775-42Phase 4Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and cardiometabolic risk (CMR) comparing Rimonabant arm with Placebo arm (2 arms). Primary endpoint: Change in liver fat content. Started Sep 2007; status: terminated.
02
Drugs
rimonabant
03
Conditions
obesitycardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2007-000775-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000775-42.